Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.

http://www.wikidata.org/entity/Q46580276

about

Pathogenesis of systemic lupus erythematosus CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus Intrarenal cytokine gene expression in lupus nephritis Enhanced IL-10 production in vitro by monocytes in autoimmune haemolytic anaemia.Assessing the human immune system through blood transcriptomics.Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?A genomic approach to human autoimmune diseases.Cytokines and systemic lupus erythematosus Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis Immunopathology and the gene therapy of lupus.Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus.Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation Mechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia.A single mid-gestation exposure to TCDD yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice.Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.Effect of pregnancy on serum cytokines in SLE patients Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.Estrogens in pregnancy and systemic lupus erythematosus.Sympathetic modulation of immunity: relevance to disease.Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus.A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.Glutathione dysregulation and the etiology and progression of human diseases.Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis.IL-12 receptor 1β deficiency with features of autoimmunity and photosensitivity.Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells.Cytokine-induced monocyte characteristics in SLE Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy.Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus.Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.Polarization of T Lymphocytes Is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB/c Mice.

P2860

Q24672873-479BFD10-B70E-4E0B-A964-19AB749C8E91 Q24815777-8305FAD6-A8F0-48AC-B33C-FA754D3DA077 Q26782454-4C70BB57-1E5D-4357-9167-5B72734934B7 Q28088753-0FA0CB7F-1A44-4ACA-B6D7-582398201A8D Q33275679-4A4314C1-12C1-4D01-A8A6-225591FC3748 Q33330730-188692CB-372D-473B-9EE9-76DB80EB3725 Q33629522-EB587FB0-881B-4262-A777-DC6A325591C9 Q33692615-58B1E9D3-C402-46B2-9670-849B77664740 Q33762839-6626DF13-A9A1-402E-B747-F0312FF653E4 Q33873329-30B84105-82FF-46C4-A31B-031862292ECF Q34412837-102C4D85-764A-4D28-BC6E-951719C726E2 Q34920423-C42A98CD-B782-4C3C-BFEC-D5B877398220 Q35122166-2123684B-F103-4456-A736-71FFDC44BFAB Q35144045-D9F28E21-B1B4-4F63-87A1-C9939F9C0F4E Q35554902-6C445EC0-E3A5-431A-9C9E-02157BB804F8 Q35557372-C968706D-DC0E-40FC-BD84-269E1174E98C Q35561441-30BB938F-F450-41D9-B4BF-32299CFCC66B Q35581087-FFC830D1-F3C7-4083-A932-F45C8C0B0AEC Q35637856-8F8BFBA3-1DC3-4619-AA00-BAD4917A8087 Q35680472-6A677467-C34B-4E46-B3EC-31A8CB1B2253 Q36245748-81C42B0D-B08C-44E5-AA05-1B762058DFFE Q36536967-C7FC53AA-E6C5-4512-A104-FBDF2BF6990D Q36541329-29801D6D-70FA-4680-AAEC-1AD57A1C657D Q36552147-7E80312A-499B-47B1-B748-147FF6E813D3 Q37207041-357E217E-F1E5-4D6E-82EA-FADACA0C0A77 Q37211862-9A2FAFB9-6E45-4332-A1F7-DBC2311131AE Q37320550-2314071D-B6DB-4520-92F2-96CF5DEB9351 Q37372896-83738124-FAC9-4D85-8759-F11EAEDB4046 Q37719559-0CEFF9D0-DCC6-41FD-B4EC-0DC3CFAE20E5 Q37849465-A7C38169-DAC4-4C17-8B46-43D8BF62632A Q39318071-0C56CB0B-7338-4607-81C6-07AE72EE939F Q40835082-34F59F8B-9794-4B8F-A374-4194955FDDBB Q41680342-CBD0B4D1-25CA-41FB-8C4E-064B3E515413 Q42141284-45FF7DFA-00FD-418D-896A-DE1099064A99 Q43212382-EE92EFFF-ABC5-42BE-9D26-021999769AA1 Q43907857-CAC94CD2-1834-4867-A0B2-F5A5444D3CA9 Q43920530-C3EEC585-D7D7-44A7-B7B7-F157F6638F3A Q44051759-95DD16FF-3E5D-4B31-BBB4-8FE8CE693F1A Q44490557-65F17021-A5C1-49B9-839F-4083287CCBEF Q46304821-3A290263-D370-4102-A9A6-BC10C5F48A3F

P2860

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.

http://www.wikidata.org/entity/Q46580276

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Decreased production of interl ...... systemic lupus erythematosus.

@en

Decreased production of interl ...... systemic lupus erythematosus.

@nl

type

label

Decreased production of interl ...... systemic lupus erythematosus.

@en

Decreased production of interl ...... systemic lupus erythematosus.

@nl

prefLabel

Decreased production of interl ...... systemic lupus erythematosus.

@en

Decreased production of interl ...... systemic lupus erythematosus.

@nl

P1433

Q46580276-9FB722EE-3D46-4E9F-B1F3-59E4575486E1

P1476

Q46580276-19809FC7-7B84-42C6-8AF8-14CFDB829D1A

P2093

Q46580276-011F32F0-4F5C-4BAD-B7D9-1C395A8EF3F7

Q46580276-57A43371-0861-43AC-ABCE-AD22E633C071

Q46580276-7D59BD9A-4414-4E2D-98CD-48207EBF0979

Q46580276-A7E839D8-2AB8-4884-BDA2-3961D12246C7

Q46580276-AF3C5039-55DD-4A19-90B1-DE9ACD2350D2

Q46580276-BAB50C04-AB1A-4172-8C24-17AE9CD4600A

Q46580276-BAD5A1F4-91C8-4AE2-BE9A-CB0E914DE36C

P2860

Q46580276-02E1EDEB-D501-4A48-A8DE-AB22BF5D8805

Q46580276-20D1F54E-8E59-4A0D-A85A-7EFA0BE7B193

Q46580276-22B58195-411F-4B23-9B75-C2A309D7FBA6

Q46580276-44B7A5DF-7D25-4DAB-AA95-013ABA453ACC

Q46580276-4F9ABB48-4310-4BFA-8DA5-B8002F991E88

Q46580276-59834A4B-CEEF-4FDD-8359-A4BEF478CBCB

Q46580276-77A5B0B6-2C5F-4ACE-AFDB-569D51F48116

Q46580276-8181906D-7A42-4585-B53E-6E8FA13663C4

Q46580276-856D7E15-2C51-4FF0-9CDD-94E889FDE8D8

Q46580276-89A4CF56-44A6-4538-80E3-F1D073F2A8D2

P304

Q46580276-860E6A94-2CCD-43F9-81D7-B85D65FF3DF4

P31

Q46580276-94735A9A-1BC8-4788-8923-839D12B31E48

P356

Q46580276-4C26960A-3AFF-4258-AF94-5EE1B4C440F4

P433

Q46580276-0A32FCAA-C743-4F15-BF7B-1CFF632E4C42

P478

Q46580276-FCFFF2F4-BDB2-48F7-ABEE-FFCD8996AE70

P577

Q46580276-69E34E9F-A782-4F02-9177-F3530C424EDB

P698

Q46580276-46C913D0-8425-428B-A17D-0D55E4BCDC36

P921

Q46580276-0B6313A1-7A06-4FDD-9DA7-F0DCCD72F25B

Q46580276-c7706c9b-86e7-491c-a238-2be0b65ad6dc

P356

1529-0131(199805)41:5%3C838::AID-ART10%3E3.0.CO;2-S

P1433

Arthritis & Rheumatology

P1476

Decreased production of interl ...... systemic lupus erythematosus.

@en

P2093

Behrendsen SC

http://www.w3.org/2001/XMLSchema#string

Gray JD

http://www.w3.org/2001/XMLSchema#string

Horwitz DA

http://www.w3.org/2001/XMLSchema#string

Kubin M

http://www.w3.org/2001/XMLSchema#string

Ohtsuka K

http://www.w3.org/2001/XMLSchema#string

Rengaraju M

http://www.w3.org/2001/XMLSchema#string

Trinchieri G

http://www.w3.org/2001/XMLSchema#string

P2860

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

The 1982 revised criteria for the classification of systemic lupus erythematosus

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome.

Measurement of systemic lupus erythematosus activity in clinical research.

P304

838-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

1998-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9588735

http://www.w3.org/2001/XMLSchema#string

P921